Asuragen Inc - Product Pipeline Analysis, 2020 Update

Summary

Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that offers laboratory medicine solutions. The company's products include amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approval, development, discovery, partnered research and development and tumor bank programs. Asuragen’s custom reagents comprise armored reagents, in vitro transcribed RNA and plasmid DNA kits. It offers diagnostic products for use in clinical laboratories and bio/pharma partners’ diagnostic needs. The company distributes its products across Algeria, Australia, Austria, Belgium, Brazil, Bulgaria, Denmark, Egypt, Germany, Iceland, India, the UAE, the UK and the US, among others. Asuragen is headquartered in Austin, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Asuragen Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Asuragen Inc Company Overview
Asuragen Inc Company Snapshot
Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview
Asuragen Inc – Pipeline Analysis Overview
Asuragen Inc - Key Facts
Asuragen Inc - Major Products and Services
Asuragen Inc Pipeline Products by Development Stage
Asuragen Inc Pipeline Products Overview
Companion Diagnostic Test - Huntington's Disease
Companion Diagnostic Test - Huntington's Disease Product Overview
Diagnostic Test - Neurodegenerative Disorders
Diagnostic Test - Neurodegenerative Disorders Product Overview
Diagnostic Test - Spinal Muscular Atrophy
Diagnostic Test - Spinal Muscular Atrophy Product Overview
Immunomagnetic Micro-Aperture Chip System
Immunomagnetic Micro-Aperture Chip System Product Overview
miRNA Based Sequencing Test - Colon Cancer
miRNA Based Sequencing Test - Colon Cancer Product Overview
miRNA Based Sequencing Test - Esophageal Cancer
miRNA Based Sequencing Test - Esophageal Cancer Product Overview
miRNA Based Sequencing Test - Lung Cancer
miRNA Based Sequencing Test - Lung Cancer Product Overview
miRNA Based Sequencing Test - Pancreatic Cancer
miRNA Based Sequencing Test - Pancreatic Cancer Product Overview
Signature CF Expand
Signature CF Expand Product Overview
Asuragen Inc - Key Competitors
Asuragen Inc - Key Employees
Asuragen Inc - Locations And Subsidiaries
Head Office
Recent Developments
Asuragen Inc, Recent Developments
Mar 16, 2020: Asuragen develops RNA Quant technology for coronavirus assays
Feb 24, 2020: FDA grants marketing authorisation for Fragile X Syndrome test
Nov 26, 2019: Asuragen and Wave Life Sciences to create diagnostics for Huntington's
Nov 06, 2019: Asuragen announces launch of AmplideX PCR/CE SMN1/2 Plus Kit
Oct 30, 2019: Asuragen to present at 2019 Association for Molecular Pathology (AMP) Annual Meeting
Oct 08, 2019: Asuragen to present at the 2019 American Society of Human Genetics (ASHG) Annual Meeting
Jun 11, 2019: Asuragen to present at 2019 European Society of Human Genetics (ESHG) Conference
Jun 04, 2019: Asuragen NGS System streamlines detection of NSCLC-associated DNA mutations, gene fusions, and RNA expression targets in single workflow
May 02, 2019: Asuragen announce the launch of AmplideX PCR/CE HTT kit for Huntington’s disease
Apr 02, 2019: Asuragen releases updated AmplideX PCR/CE Reporter Software
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Asuragen Inc Pipeline Products and Ongoing Clinical Trials Overview
Asuragen Inc Pipeline Products by Equipment Type
Asuragen Inc Pipeline Products by Indication
Asuragen Inc, Key Facts
Asuragen Inc, Major Products and Services
Asuragen Inc Number of Pipeline Products by Development Stage
Asuragen Inc Pipeline Products Summary by Development Stage
Companion Diagnostic Test - Huntington's Disease - Product Status
Companion Diagnostic Test - Huntington's Disease - Product Description
Diagnostic Test - Neurodegenerative Disorders - Product Status
Diagnostic Test - Neurodegenerative Disorders - Product Description
Diagnostic Test - Spinal Muscular Atrophy - Product Status
Diagnostic Test - Spinal Muscular Atrophy - Product Description
Immunomagnetic Micro-Aperture Chip System - Product Status
Immunomagnetic Micro-Aperture Chip System - Product Description
miRNA Based Sequencing Test - Colon Cancer - Product Status
miRNA Based Sequencing Test - Colon Cancer - Product Description
miRNA Based Sequencing Test - Esophageal Cancer - Product Status
miRNA Based Sequencing Test - Esophageal Cancer - Product Description
miRNA Based Sequencing Test - Lung Cancer - Product Status
miRNA Based Sequencing Test - Lung Cancer - Product Description
miRNA Based Sequencing Test - Pancreatic Cancer - Product Status
miRNA Based Sequencing Test - Pancreatic Cancer - Product Description
Signature CF Expand - Product Status
Signature CF Expand - Product Description
Asuragen Inc, Key Employees
Glossary
List of Figures
Asuragen Inc Pipeline Products by Equipment Type
Asuragen Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook